Kobold, Sebastian, Steffen, Julius, Chaloupka, Michael, Grassmann, Simon, Henkel, Jonas, Castoldi, Raffaella, Zeng, Yi, Chmielewski, Markus, Schmollinger, Jan C., Schnurr, Max, Rothenfusser, Simon, Schendel, Dolores J., Abken, Hinrich, Sustmann, Claudio, Niederfellner, Gerhard, Klein, Christian ORCID: 0000-0001-7594-7280, Bourquin, Carole ORCID: 0000-0003-3862-4583 and Endres, Stefan (2015). Selective Bispecific T Cell Recruiting Antibody and Antitumor Activity of Adoptive T Cell Transfer. JNCI-J. Natl. Cancer Inst., 107 (1). CARY: OXFORD UNIV PRESS INC. ISSN 1460-2105

Full text not available from this repository.

Abstract

One bottleneck for adoptive T cell therapy (ACT) is recruitment of T cells into tumors. We hypothesized that combining tumor-specific T cells, modified with a marker antigen and a bispecific antibody (BiAb) that selectively recognizes transduced T cells and tumor cells would improve T cell recruitment to tumors and enhance therapeutic efficacy. SV40 T antigen-specific T cells from T cell receptor (TCR)-I-transgenic mice were transduced with a truncated human epidermal growth factor receptor (EGFR) as a marker protein. Targeting and killing by combined ACT and anti-EGFR-anti-EpCAM BiAb therapy was analyzed in C57Bl/6 mice (n = six to 12 per group) carrying subcutaneous tumors of the murine gastric cancer cell line GC8 (SV40(+) and EpCAM(+)). Anti-EGFR x anti-c-Met BiAb was used for targeting of human tumor-specific T cells to c-Met(+) human tumor cell lines. Differences between experimental conditions were analyzed using the Student's t test, and differences in tumor growth with two-way analysis of variance. Overall survival was analyzed by log-rank test. All statistical tests were two-sided. The BiAb linked EGFR-transduced T cells to tumor cells and enhanced tumor cell lysis. In vivo, the combination of ACT and Biab produced increased T cell infiltration of tumors, retarded tumor growth, and prolonged survival compared with ACT with a control antibody (median survival 95 vs 75 days, P < .001). In human cells, this strategy enhanced recruitment of human EGFR-transduced T cells to immobilized c-Met and recognition of tyrosinase(+) melanoma cells by TCR-, as well as of CEA(+) colon cancer cells by chimeric antigen receptor (CAR)-modified T cells. BiAb recruitment of tumor-specific T cells transduced with a marker antigen to tumor cells may enhance efficacy of ACT.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Kobold, SebastianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Steffen, JuliusUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chaloupka, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Grassmann, SimonUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Henkel, JonasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Castoldi, RaffaellaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zeng, YiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chmielewski, MarkusUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmollinger, Jan C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schnurr, MaxUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rothenfusser, SimonUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schendel, Dolores J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Abken, HinrichUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sustmann, ClaudioUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Niederfellner, GerhardUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Klein, ChristianUNSPECIFIEDorcid.org/0000-0001-7594-7280UNSPECIFIED
Bourquin, CaroleUNSPECIFIEDorcid.org/0000-0003-3862-4583UNSPECIFIED
Endres, StefanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-417153
DOI: 10.1093/jnci/dju364
Journal or Publication Title: JNCI-J. Natl. Cancer Inst.
Volume: 107
Number: 1
Date: 2015
Publisher: OXFORD UNIV PRESS INC
Place of Publication: CARY
ISSN: 1460-2105
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ENGAGING ANTIBODY; THERAPY; LYMPHOCYTES; CANCER; TUMORS; TRIAL; IMMUNOTHERAPY; SECRETION; CARCINOMA; PROTEINSMultiple languages
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/41715

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item